Cartridge-Based Automated Rapid Test Analyzer
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application 16/855,709, filed Apr 22, 2020. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 12,560,598 | Cartridge-Based Automated Rapid Test Analyzer In force · High confidence | Genesis Intelligence, LLC | In force | High confidence | ||
| US 12,716,891 | Automated Pathogen and Antibody Rapid Test In force · High confidence | Genesis Intelligence, LLC | In force | High confidence | ||
| US 12,716,892 | Cartridge-Based Automated Rapid Test Analyzer In force · High confidence | Genesis Intelligence, LLC | In force | High confidence | ||
| US 12,730,069 | Cartridge-Based Automated Rapid Test Analyzer In force · High confidence | Genesis Intelligence, LLC | In force | High confidence | ||
| Application 16/855,709 | Virumeter for Rapid Detection of COVID19 and Other Pathogens Pending Not granted | Genesis Intelligence, LLC | Pending | Not granted | not computed |
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Genesis Intelligence, LLC.
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.